title: In silico Therapeutics for Neurogenic Hypertension and Vasovagal Syncope.
abstract: Neurocardiovascular diseases (NCVD) are the leading cause of death in the developed world and will remain so till 2020. In these diseases the pathologically changed nervous control of cardiovascular system has the central role. The actual NCV syndromes are neurogenic hypertension, representing the sympathetically mediated disorder, and vasovagal syncope, which is the vagally mediated disorders. Vasovagal syncope, the disease far from its etiological treatment, could benefit from recruiting and application of antimuscarinic drugs used in other parasympathetic disorders. The informational spectrum method (ISM), a method widely applied for the characterization of protein-protein interactions in the field of immunology, endocrinology and anti HIV drug discovery, was applied for the first time in the analysis of neurogenic hypertension and vasovagal syncope therapeutic targets. In silico analysis revealed the potential involvement of apelin in neurogenic hypertension. Applying the EIIP/ISM bioinformatics concept in investigation of drugs for treatment of vasovagal syncope suggests that 78% of tested antimuscarinic drugs could have anti vasovagal syncope effect. The presented results confirm that ISM is a promissing method for investigation of molecular mechanisms underlying pathophysiological proceses of NCV syndromes and discovery of therapeutics targets for their treatment.
authors.affiliation: Laboratory of Radiobiology and Molecular Genetics-080, Institute of Nuclear Sciences Vinča, University of Belgrade Belgrade, Serbia.
authors.forename: Tijana
authors.initials: T
authors.lastname: Bojić
authors.affiliation: Center for Multidisciplinary Research-180, Institute of Nuclear Sciences Vinča, University of Belgrade Belgrade, Serbia.
authors.forename: Vladimir R
authors.initials: VR
authors.lastname: Perović
authors.affiliation: Center for Multidisciplinary Research-180, Institute of Nuclear Sciences Vinča, University of Belgrade Belgrade, Serbia.
authors.forename: Sanja
authors.initials: S
authors.lastname: Glišić
keywords: in silico analysis; neurocardiovascular diseases; neurogenic hypertension; protein-protein interaction; vasovagal syncope
references.citation: BMC Struct Biol. 2009 Apr 07;9:21
references.pmid: 19351406
references.citation: Clin Chim Acta. 2014 Jan 20;428:1-8
references.pmid: 24055369
references.citation: Bioinformatics. 2009 May 1;25(9):1189-91
references.pmid: 19151095
references.citation: Antioxid Redox Signal. 2014 Feb 1;20(4):557-73
references.pmid: 23879244
references.citation: Curr Opin Pharmacol. 2011 Apr;11(2):138-43
references.pmid: 21257347
references.citation: Expert Opin Drug Discov. 2011 Dec;6(12):1263-70
references.pmid: 22647065
references.citation: Vojnosanit Pregl. 2012 Dec;69(12):1084-90
references.pmid: 23424963
references.citation: Proteins. 2008 Feb 15;70(3):855-62
references.pmid: 17803213
references.citation: Cardiovasc Drugs Ther. 1997 Jan;10(6):687-92
references.pmid: 9110111
references.citation: BMC Struct Biol. 2009 Sep 28;9:62
references.pmid: 19785758
references.citation: Trends Pharmacol Sci. 2015 Sep;36(9):560-7
references.pmid: 26143239
references.citation: IEEE Trans Biomed Eng. 1985 May;32(5):337-41
references.pmid: 2581884
references.citation: Sleep. 2001 Nov 1;24(7):753-8
references.pmid: 11683478
references.citation: J Hum Hypertens. 2012 Aug;26(8):463-75
references.pmid: 21734720
references.citation: PLoS One. 2013 Apr 26;8(4):e61572
references.pmid: 23658611
references.citation: Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
references.pmid: 15034147
references.citation: Peptides. 2012 Sep;37(1):171-3
references.pmid: 22820556
references.citation: Prog Cardiovasc Dis. 2013 Jan-Feb;55(4):425-33
references.pmid: 23472781
references.citation: Am J Cardiol. 1996 Aug 15;78(4):480-2
references.pmid: 8752198
references.citation: Neurochem Int. 2013 Nov;63(6):535-40
references.pmid: 24083989
references.citation: Bioinformatics. 2011 Oct 1;27(19):2772-3
references.pmid: 21821666
references.citation: Arch Med Sci. 2012 Dec 20;8(6):970-7
references.pmid: 23319968
references.citation: Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3338-42
references.pmid: 1565624
references.citation: Curr Pharm Des. 2014;20(31):4944-52
references.pmid: 24320038
references.citation: Curr Med Chem. 2007;14(4):441-53
references.pmid: 17305545
references.citation: Eur Heart J. 1999 Dec;20(23):1745-51
references.pmid: 10562483
references.citation: Peptides. 2015 Jan;63:43-6
references.pmid: 25447414
references.citation: Curr Protein Pept Sci. 2008 Oct;9(5):493-506
references.pmid: 18855700
references.citation: J Clin Invest. 2008 Oct;118(10):3343-54
references.pmid: 18769630
references.citation: Matrix Biol. 2008 Mar;27(2):96-106
references.pmid: 17988845